Patrick G. Pilié

Patrick G. Pilié is an Associate Professor at The University of Texas MD Anderson Cancer Center. His research focuses on genitourinary oncology, specifically prostate and bladder cancer, with an emphasis on androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPI). His recent work includes the phase 1/2 PETRANHA trial evaluating saruparib with ARPI and ADT in metastatic hormone-sensitive prostate cancer, the EXTEND trial on oligometastatic disease, and investigations into KDM6A-mediated genomic instability in bladder cancer. He also studies the influence of adiposity and cardiometabolic health on treatment outcomes, contributing to publications in *The Lancet* and *European Urology*.